These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 26904023)

  • 1. Starved and Asphyxiated: How Can CD8(+) T Cells within a Tumor Microenvironment Prevent Tumor Progression.
    Zhang Y; Ertl HC
    Front Immunol; 2016; 7():32. PubMed ID: 26904023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipids for CD8
    Wu D; Chen Y
    Front Immunol; 2022; 13():1020422. PubMed ID: 36275711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High DGK-α and disabled MAPK pathways cause dysfunction of human tumor-infiltrating CD8+ T cells that is reversible by pharmacologic intervention.
    Prinz PU; Mendler AN; Masouris I; Durner L; Oberneder R; Noessner E
    J Immunol; 2012 Jun; 188(12):5990-6000. PubMed ID: 22573804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting PD-1 and Tim-3 Pathways to Reverse CD8 T-Cell Exhaustion and Enhance Ex Vivo T-Cell Responses to Autologous Dendritic/Tumor Vaccines.
    Liu J; Zhang S; Hu Y; Yang Z; Li J; Liu X; Deng L; Wang Y; Zhang X; Jiang T; Lu X
    J Immunother; 2016 May; 39(4):171-80. PubMed ID: 27070448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-infiltrating lymphocytes, forkhead box P3, programmed death ligand-1, and cytotoxic T lymphocyte-associated antigen-4 expressions before and after neoadjuvant chemoradiation in rectal cancer.
    Teng F; Meng X; Kong L; Mu D; Zhu H; Liu S; Zhang J; Yu J
    Transl Res; 2015 Dec; 166(6):721-732.e1. PubMed ID: 26209749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expansion of Tumor-reactive T Cells From Patients With Pancreatic Cancer.
    Meng Q; Liu Z; Rangelova E; Poiret T; Ambati A; Rane L; Xie S; Verbeke C; Dodoo E; Del Chiaro M; Löhr M; Segersvärd R; Maeurer MJ
    J Immunother; 2016; 39(2):81-9. PubMed ID: 26849077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic Challenges in Anticancer CD8 T Cell Functions.
    Amitrano AM; Kim M
    Immune Netw; 2023 Feb; 23(1):e9. PubMed ID: 36911801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metal-Phenolic Nanomedicines Regulate T-Cell Antitumor Function for Sono-Metabolic Cancer Therapy.
    Yan J; Li W; Tian H; Li B; Yu X; Wang G; Sang W; Dai Y
    ACS Nano; 2023 Aug; 17(15):14667-14677. PubMed ID: 37486249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with the PPARα agonist fenofibrate improves the efficacy of CD8
    Hasanpourghadi M; Chekaoui A; Kurian S; Kurupati R; Ambrose R; Giles-Davis W; Saha A; Xiaowei X; Ertl HCJ
    Mol Ther Oncolytics; 2023 Dec; 31():100744. PubMed ID: 38075243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The HIF-1α hypoxia response in tumor-infiltrating T lymphocytes induces functional CD137 (4-1BB) for immunotherapy.
    Palazón A; Martínez-Forero I; Teijeira A; Morales-Kastresana A; Alfaro C; Sanmamed MF; Perez-Gracia JL; Peñuelas I; Hervás-Stubbs S; Rouzaut A; de Landázuri MO; Jure-Kunkel M; Aragonés J; Melero I
    Cancer Discov; 2012 Jul; 2(7):608-23. PubMed ID: 22719018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MART-1-specific melanoma tumor-infiltrating lymphocytes maintaining CD28 expression have improved survival and expansion capability following antigenic restimulation in vitro.
    Li Y; Liu S; Hernandez J; Vence L; Hwu P; Radvanyi L
    J Immunol; 2010 Jan; 184(1):452-65. PubMed ID: 19949105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-infiltrating lymphocytes expressing the tissue resident memory marker CD103 are associated with increased survival in high-grade serous ovarian cancer.
    Webb JR; Milne K; Watson P; Deleeuw RJ; Nelson BH
    Clin Cancer Res; 2014 Jan; 20(2):434-44. PubMed ID: 24190978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of FABP5 in T Cell Lipid Metabolism and Function in the Tumor Microenvironment.
    Jin R; Hao J; Yu J; Wang P; Sauter ER; Li B
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of CD8
    He T; Hu C; Li S; Fan Y; Xie F; Sun X; Jiang Q; Chen W; Jia Y; Li W
    Heliyon; 2024 Jun; 10(12):e33144. PubMed ID: 39005910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological effects on anaplerotic pathways alter the metabolic landscape in the tumor microenvironment, causing unpredictable, sustained anti-tumor immunity.
    Udono H; Nishida M
    Int Immunol; 2022 Feb; 34(3):133-140. PubMed ID: 34491338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression.
    Berghuis D; Santos SJ; Baelde HJ; Taminiau AH; Egeler RM; Schilham MW; Hogendoorn PC; Lankester AC
    J Pathol; 2011 Feb; 223(3):347-57. PubMed ID: 21171080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TIGIT and PD-1 impair tumor antigen-specific CD8⁺ T cells in melanoma patients.
    Chauvin JM; Pagliano O; Fourcade J; Sun Z; Wang H; Sander C; Kirkwood JM; Chen TH; Maurer M; Korman AJ; Zarour HM
    J Clin Invest; 2015 May; 125(5):2046-58. PubMed ID: 25866972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
    Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
    Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SENP7 senses oxidative stress to sustain metabolic fitness and antitumor functions of CD8+ T cells.
    Wu Z; Huang H; Han Q; Hu Z; Teng XL; Ding R; Ye Y; Yu X; Zhao R; Wang Z; Zou Q
    J Clin Invest; 2022 Apr; 132(7):. PubMed ID: 35143421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-Infiltrating γδ T Lymphocytes: Pathogenic Role, Clinical Significance, and Differential Programing in the Tumor Microenvironment.
    Lo Presti E; Dieli F; Meraviglia S
    Front Immunol; 2014; 5():607. PubMed ID: 25505472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.